ECP 2022 Final Programme

Sunday, 4 Sept Scientific Programme a Sunday 32 014 11:30–11:40 An innovative artificial intelligence based application for the differentiation of invasive adenocarcinoma from pseudoinvasion in colorectal polyps Lina Chen, Canada Z. Yang, B. Wang, D. Driman, C. Ling, Q. Zhang 015 11:40–11:50 MMR-deficient crypts detection by immunohistochemistry in normal colonic mucosa of patients with MMR deficient (dMMR)/MicroSatellite Instable (MSI) colorectal cancer: a helpful tool for the diagnosis of Lynch syndrome Magali Svrcek, France S. Breton, I. Sourrouille, N. Basset, E. Guillerm, I. Brocheriou, D. Eneaa, P. Bourgoin, A. Duval, T. Andre, M. Muleris, F. Coulet 016 11:50–12:00 Tumour budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR) Magali Svrcek, France D. Basile, C. Broudin, J. Emile, A. Falcoz, F. Pagès, L. Mineur, J. Bennouna, C. Louvet, P. Artru, S. Fratte, F. Ghiringhelli, T. Andre, V. Derangère, D. Vernerey, J. Taieb OFP-02 Oral Free Paper Session 08:30–12:00 Rio Joint Oral Free Paper Session Gynaeco- logical Pathology / Cytopathology Chairs: Ben Davidson, Norway Ivana Kholova, Finland 001 08:30–08:40 Consensus based recommendations for the diagnosis of Serous Tubal Intraepithelial Carcinoma; an international Delphi study Joep Bogaerts, The Netherlands M. van Bommel, M. Steenbeek, R. Hermens, J. de Hullu, J. van der Laak, M. Simons 002 08:40–08:50 Endocervical endometrioid adenocarcino- ma: clinicopathologic characterisation of a rare human papillomavirus-independent tumour type Anjelica Hodgson, Canada S. Stolnicu, C. Mateoiu, T. Kiyokawa, A. Felix, H. Trihia, L. De Brot, G. Karpathiou, R. Soslow, C. Parra-Herran, W. McCluggage, K. Park 003 08:50–09:00 QPOLE; a rapid, simple and cheap approach for POLE assessment in endometrial cancer by multiplex qPCR Anne-Sophie Van Den Heerik, The Netherlands N. Ter Haar, L. Vermij, J. Jobsen, M. Brinkhuis, S. Roothaan, A. Leon-Castillo, G. Ørtoft, E. Hogdall, C. Hogdall, T. van Wezel, L. Lutgens, E. van der Steen-Banasik, J. McAlpine, C. Creutzberg, V. Smit, B. Gilks, N. Horeweg, T. Bosse 004 09:00–09:10 Molecular characterisation of endometrial carcinoma and prognostic risk group classification María Emilia Brizzi, Spain Á. López-Janeiro, V. Heredia Soto, A. Berjón, L. Yébenes, A. Peláez-García, M. Mendiola, D. Hardisson 005 09:10–09:20 Comparison of tumour infiltrating lympho- cytes between endometrial carcinoma primary tumours and matched metastases Diana F. Martins, Portugal E. Sustatxa, M. Pires, L. Azevedo, C. Jerónimo, C. Bartosch 006 09:20–09:30 DNA methylation analysis of endometrial carcinomas identifies molecularly and clinically distinct subgroups Basile Tessier-Cloutier, USA J. Li, F. Kommoss, A. Lum, D. Chiu, V. Yuan, S. Leung, D. Huntsman, J. McAlpine, A. von Deimling